EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prediction of CKD Progression and Cardiovascular Events Using Albuminuria and Pulse Wave Velocity

Rasmus Kirkeskov Carlsen, Dinah Sherzad Khatir, Danny Jensen, Henrik Birn, Niels Henrik Buus

Kidney and Blood Pressure Research · 2023

DOI: 10.1159/000530887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney and Blood Pressure Research, 2023. Verfasst von Rasmus Kirkeskov Carlsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic kidney disease (CKD) is associated with cardiovascular disease (CVD) and death. Albuminuria is an established risk factor, but additional biomarkers predicting CKD progression or CVD are needed. Arterial stiffness is an easily measurable parameter that has been associated with CVD and mortality. We evaluated the ability of carotid-femoral pulse wave velocity (PWV) and urine albumin-creatinine (UAC) ratio to predict CKD progression, cardiovascular events, and mortality in a cohort of CKD patients.

Methods

In CKD stage 3–5 patients, PWV and UAC were measured at baseline. CKD progression was defined as 50% decline in estimated glomerular filtration rate (eGFR), initiation of dialysis, or renal transplantation. A composite endpoint was defined as CKD progression, myocardial infarction, stroke, or death. Endpoints were analyzed using Cox regression analysis adjusted for possible confounders.

Results

We included 181 patients (median age 69 [interquartile range 60–75] years, 67% males) with a mean eGFR of 37 ± 12 mL/min/1.73 m2 and UAC 52 (5–472) mg/g. Mean PWV was 10.6 m/s. Median follow-up until first event was 4 (3–6) years with 44 and 89 patients reaching a CKD progression or composite endpoint, respectively. UAC (g/g) significantly predicted both CKD progression (HR 1.5 [1.2; 1.8]) and composite endpoints (HR 1.4 [1.1; 1.7]) in adjusted Cox regression. In contrast, PWV (m/s) was not associated with neither CKD progression (HR 0.99 [0.84; 1.18]) nor the composite endpoint (HR 1.03 [0.92; 1.15]).

Conclusion

In an aging CKD population, UAC predicted both CKD progression and a composite endpoint of CKD progression, cardiovascular events, or death, while PWV did not.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicCardiovascular DiseasesMaleHumansMiddle AgedAgedFemaleAlbuminuriaPulse Wave AnalysisRenal DialysisRisk FactorsDisease ProgressionGlomerular Filtration Rate

Stichwörter der Autor:innen

Cardiovascular eventsChronic kidney diseaseMortalityProgressionPulse wave velocityUrine albumin excretion

Autor:innen und Institutionen

  • Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Department of Biomedicine, HEALTH, Aarhus University, Aarhus, Denmark.

Zitieren

APA

Carlsen, R. K., Khatir, D. S., Jensen, D., Birn, H., & Buus, N. H. (2023). Prediction of CKD Progression and Cardiovascular Events Using Albuminuria and Pulse Wave Velocity. Kidney and Blood Pressure Research. https://doi.org/10.1159/000530887

Vancouver

Carlsen RK, Khatir DS, Jensen D, Birn H, Buus NH. Prediction of CKD Progression and Cardiovascular Events Using Albuminuria and Pulse Wave Velocity. Kidney and Blood Pressure Research. 2023. doi:10.1159/000530887

BibTeX
@article{Carlsen2023,
  author = {Carlsen, Rasmus Kirkeskov and Khatir, Dinah Sherzad and Jensen, Danny and Birn, Henrik and Buus, Niels Henrik},
  title = {Prediction of CKD Progression and Cardiovascular Events Using Albuminuria and Pulse Wave Velocity},
  journal = {Kidney and Blood Pressure Research},
  year = {2023},
  doi = {10.1159/000530887}
}
Kostenlos starten →